Zhang L, et al. - Researchers assessed the current treatment approaches for Coats’ disease by intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents (ranibizumab or conbercept) combined with laser therapy for the efficacy during the treatment. In Coats’ disease, an effective therapeutic option was the intravitreal injection of ranibizumab or conbercept combined with laser therapy. Also, no significant adverse effects of intravitreal injection of ranibizumab or conbercept were noted. In Coats’ disease, this treatment appeared to offer visual improvement.